Sensei Biotherapeutics, Inc. (SNSE)

Sensei Biotherapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	8.67	9.99	13.01	17.8	7.16
Short-Term Investments	12.52	31.34	52.75	89.32	140.46
Cash & Short-Term Investments	21.18	41.34	65.76	107.12	147.62
Cash Growth	-48.75%	-37.14%	-38.61%	-27.44%	789.50%
Other Current Assets	0.32	0.59	1.49	1.47	0.92
Total Current Assets	21.51	41.93	67.25	108.59	148.54
Net Property, Plant & Equipment	1.38	3.38	7.04	9.72	4.64
Other Long-Term Assets	0.02	0.05	0.09	0.06	0.04
Total Assets	22.9	45.36	74.37	118.38	153.23
Accrued Expenses	2.8	3.13	3.2	6.94	4.21
Current Portion of Leases	1.45	2.32	2.44	2.13	0.68
Total Current Liabilities	4.25	5.45	5.64	9.07	4.89
Long-Term Leases	0.06	1.53	3.77	5.9	1.67
Other Long-Term Liabilities	-	-	0.07	-	0.15
Total Long-Term Liabilities	0.06	1.53	3.84	5.9	1.82
Total Liabilities	4.31	6.98	9.48	14.97	6.71
Common Stock	-	-	0	0	0
Additional Paid-in Capital	301.73	300.45	297	302.2	296.05
Accumulated Other Comprehensive Income	0	-0.01	-0.21	-1	-0.33
Retained Earnings	-283.14	-262.05	-231.9	-197.79	-149.21
Shareholders' Equity	18.59	38.39	64.9	103.41	146.51
Total Liabilities & Equity	22.9	45.36	74.37	118.38	153.23
Total Debt	1.51	3.85	6.21	8.03	2.35
Net Cash (Debt)	19.68	37.49	59.55	99.08	145.27
Net Cash Growth	-47.52%	-37.04%	-39.90%	-31.79%	813.00%
Net Cash Per Share	15.61	29.85	42.61	64.54	104.84
Book Value	18.59	38.39	64.9	103.41	146.51
Book Value Per Share	14.75	30.57	46.43	67.36	105.74
Tangible Book Value	18.59	38.39	64.9	103.41	146.51
Tangible Book Value Per Share	14.75	30.57	46.43	67.36	105.74

Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q